| 摘要 |
A pharmaceutical composition and method of treatment is provided for retarding and/or reducing cachexia in humans due carcinoma, sarcoma, and leukemia which comprises the administration of a therapeutically effective amount of a composition comprising friedelan-3-one contained in a physiologically acceptable solution sufficient to retard and/or reduce said cachexia.
|
